Silo Pharma, Inc.
Silo Pharma, Inc.
SARASOTA, FL
Loading...
Price History
Market Data
| Market Cap | 761,536.09 |
| P/E Ratio | - |
| P/B Ratio | 0.12 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.21 |
| Current Ratio | 11.36 |
| Currency | USD |
Key Financial Metrics
72,102.00
Revenue
-4.23M
Net Income
-
EPS (Diluted)
-9.23M
Free Cash Flow
Profitability
Gross Margin
38.6%
Operating Margin
-5937.0%
Net Profit Margin
-5863.5%
EBITDA
-4.28M
Returns & Efficiency
Return on Assets (ROA)
-55.6%
Return on Equity (ROE)
-67.0%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
7.61M
Total Debt
-
Debt to Equity
0.21x
Current Ratio
11.36
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Apparel & Other Textile Products |
| HQ | SARASOTA, FL |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$761.54K
P/E Ratio (TTM)-
Price to Book0.12
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin38.6%
Operating Margin-5937.0%
Net Margin-5863.5%
ROE-67.0%
ROA-55.6%
Leverage & Liquidity
Debt to Equity0.21
Current Ratio11.36
Total Debt-
Total Assets$7.61M
Stockholders' Equity$6.31M
Income Statement (FY 2025)
Revenue$72.10K
Gross Profit$27.81K
Operating Income$-4.28M
Net Income$-4.23M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-9.23M
Cash & Equivalents$4.75M
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 677 N. WASHINGTON BLVD SARASOTA, FL 34236 |
| Phone | N/A |
| Incorporated | NV, US |
| EIN | 462137136 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.67M |
| Stockholders' Equity | $6.31M |
| Cash & Equivalents | $4.75M |
Recent Filings
View All
424B3
Prospectus (Rule 424b3)
Prospectus filed under Rule 424(b)(3)
Filed: 2026-04-16
Local
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2026-04-15
Local
424B3
Prospectus (Rule 424b3)
Prospectus filed under Rule 424(b)(3)
Filed: 2026-04-14
Local
POS AM
Post-Effective Amendment
Post-effective amendment to registration statement
Filed: 2026-04-14
Local
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2026-04-13
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-27
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-23
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-13
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-13
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-09-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-09
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-28
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Silo Pharma, Inc. |
| Ticker | SILO |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Apparel & Other Textile Products |
| Headquarters | SARASOTA, FL |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 761,536.09 |
| Revenue | 72,102.00 |
| Net Income | -4.23M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -5863.5% |
| ROE | -67.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...